Skip to content

Hexa Time Capsule: A Single-Center, Self-Controlled Exploratory Study on Its Effects on Fatigue and Sleep Quality in People with Sub-Health

Hexa Time Capsule: A Single-Center, Self-Controlled Exploratory Study on Its Effects on Fatigue and Sleep Quality in People with Sub-Health

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128735
Enrollment
Unknown
Registered
2026-07-24
Start date
2026-07-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, sleep problems, mood swings, and trouble thinking clearly

Interventions

treatment group:Test food consumption,Hexa Time Capsule

Sponsors

The First People's Hospital of Kunshan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 30-50 (inclusive), evenly split between men and women; 2. Fatigue Severity Scale (FSS) total score >=18 and =11; 4. Determined to be a mildly to moderately sub-healthy group according to the Sub-Health Measurement Scale (SHMS V1.0); 5. Can cooperate with researchers to independently complete all research tests and questionnaires; 6. During the study, participants agree not to take part in other interventional studies; 7. Voluntarily join the study, sign the informed consent form before the study, fully understand the study’s content, process, and any possible adverse events, and be willing to follow the study’s requirements and procedures;

Exclusion criteria

Exclusion criteria: 1.Women Preparing for Pregnancy, Pregnant Women, and Lactating Women; 2.Suffering from severe organic diseases, metabolic diseases, infectious diseases, trauma, mental disorders, or cognitive impairments; having a history of tuberculosis; having a history of major surgery; 3.Have been taking medication regularly in the past 3 months (at least twice a week for more than a month). 4.Those whose physical examination results within the past 3 months meet any of the following conditions need to be excluded: a. Liver function: Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 2.5 times the upper limit of normal (ULN). b. Kidney function: Serum creatinine > 1.2 times the upper limit of normal (ULN). c. Others: The investigator determines the presence of other laboratory abnormalities with clear clinical significance that may affect the safety of study participants or the reliability of study results. 5.In the past week, the average daily intake of caffeine exceeded 400 mg (approximately 800 mL of American coffee). 6.Regular consumption of mushrooms, legumes, or oat bran in the past month (defined as =3 times per week); 7.Habitual heavy drinking, with an average alcohol intake of >2 standard drinks/day (beer >500ml/day, red wine >200ml/day, spirits >50ml/day); 8.Smokes more than 10 cigarettes a day; 9.Regularly taking nutritional supplements in the past month (defined as at least 3 times a week); 10.Known to be allergic to the study components, or have a history of drug allergies or allergic diseases; 11.People who have trouble swallowing capsules; 12.People working night shifts; those planning to make big changes to their schedule during the study (like going on overseas trips or traveling); 13.Other conditions that, according to the researcher’s judgment, are not suitable or would hinder participation.

Design outcomes

Primary

MeasureTime frame
Fatigue Severity Scale (FSS) Score, Pittsburgh Sleep Quality Index (PSQI);

Secondary

MeasureTime frame
Self-Rated Sleep Status Scale (SRSS), Depression-Anxiety-Stress Scale, Clinical Memory Scale, Stroop Test, Health Survey Short Form, 6-Minute Walk Test, Mini-Mental State Exam, Self-Assessment Questio;Visceral fat;C-reactive protein (CRP), interleukin-6 (IL-6);Waist and belly measurements;Complete blood count, urinalysis, liver function (alanine aminotransferase, aspartate aminotransferase), kidney function (creatinine);Gut microbiota diversity (Alpha diversity index), relative abundance of gut microbiota; testing gut short-chain fatty acids (acetate, propionate, butyrate);8-Hydroxy-2'-deoxyguanosine (8-OHdG), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD).;Melatonin;

Countries

China

Contacts

Public ContactGuo Zhengli

The First People's Hospital of Kunshan

350834416@qq.com+86 10 12345678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026